The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Exploring skin toxicity as a predictor of response in urothelial carcinoma patients treated with enfortumab vedotin: A meta-analysis of Kaplan-Meier reconstructed individual patient data.
 
Gabriela Gazzoni
No Relationships to Disclose
 
Isadora Mamede
Stock and Other Ownership Interests - Fleury Group
Patents, Royalties, Other Intellectual Property - A patent application as an inventor for a mobile application on obstructive sleep apnea craniofacial morphology detection with facial recognition AI technology and its methodology has been filed with INPI under the number BR 10 2023 017494 9
 
Guilherme Lopes
No Relationships to Disclose
 
Matthew Zibelman
Honoraria - Pfizer
Consulting or Advisory Role - Adicet Bio; AVEO; Exelixis; Merck
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst)
 
Ana Paula Cardoso
Honoraria - Adium Pharma; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb/Medarex; Ipsen; Janssen Oncology; Merck Serono; MSD Oncology; Novartis/Pfizer; Zodiac Pharma
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Janssen Oncology; Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca; Bayer; Janssen Oncology; MSD Oncology; Novartis
Travel, Accommodations, Expenses - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; Zodiac Pharma